| 000 | 01800 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514055154.0 | ||
| 264 | 0 | _c20030905 | |
| 008 | 200309s 0 0 eng d | ||
| 022 | _a0929-1903 | ||
| 024 | 7 |
_a10.1038/sj.cgt.7700530 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Xi | |
| 245 | 0 | 0 |
_aBifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth. _h[electronic resource] |
| 260 |
_bCancer gene therapy _cFeb 2003 |
||
| 300 |
_a105-11 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xgenetics |
| 650 | 0 | 4 |
_aBifidobacterium _xdrug effects |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCell Hypoxia |
| 650 | 0 | 4 |
_aCollagen _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 |
_aDrug Resistance, Bacterial _xgenetics |
| 650 | 0 | 4 | _aEndostatins |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 |
_aLiver Neoplasms, Experimental _xmicrobiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aPeptide Fragments _xadministration & dosage |
| 650 | 0 | 4 |
_aPlasmids _xgenetics |
| 650 | 0 | 4 |
_aPolymerase Chain Reaction _xmethods |
| 700 | 1 | _aFu, Geng-Feng | |
| 700 | 1 | _aFan, Yan-Rong | |
| 700 | 1 | _aLiu, Wen-Hua | |
| 700 | 1 | _aLiu, Xin-Juan | |
| 700 | 1 | _aWang, Jian-Jun | |
| 700 | 1 | _aXu, Gen-Xing | |
| 773 | 0 |
_tCancer gene therapy _gvol. 10 _gno. 2 _gp. 105-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.cgt.7700530 _zAvailable from publisher's website |
| 999 |
_c12338102 _d12338102 |
||